GlassScriptPhysician profile
Michael Bolan Liu
NPI 1063078046
$14,043.29
in general payments reported to CMS, 2019-2025
7 companies · $13K in 2025
The $13K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $123 · 2023: $382 · 2024: $135 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $7,500 · Travel and Lodging: $3,267 · Food and Beverage: $2,956 · Education: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $7,500.00 |
| Travel and Lodging | $3,267.01 |
| Food and Beverage | $2,955.62 |
| Education | $197.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,566.67 | 2022-2025 | |
| Boston Scientific Corporation | $5,365.43 | 2025 | General - Therapies, Farapulse |
| Abbott Laboratories | $363.40 | 2025 | Ensite, Perclose Prostyle |
| Astrazeneca Pharmaceuticals LP | $309.37 | 2024-2025 | Saphnelo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $273.61 | 2023 | Lifevest |
| Edwards Lifesciences Corporation | $108.32 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| W. L. Gore & Associates, INC. | $56.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.